论文信息 - Can Immune-related adverse events serve as clinical biomarkers of PD-1/PD-L1 inhibitor efficacy in Pan-Cancer Patients? - 字舞流文

Can Immune-related adverse events serve as clinical biomarkers of PD-1/PD-L1 inhibitor efficacy in Pan-Cancer Patients?

Ziqi Ye | Jie Chen | Yanfang Zhang | Zixue Xuan | Si Yang | Hongyu Yang | Qingwei Zhao | Shiyu Zheng | Yun-Han Hong